Search Market Research reports

Global Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography (2017 - 2022)

The European pancreatic cancer market is expected to grow modestly from USD 519 million in 2015, growing at a CAGR of 10-17%. Globally, pancreatic cancer is the 12th most common cancer in men and 11th most common cancer in women. Addiction to cigarettes and health history are considered to be the foremost reasons increasing the risk. Europe Pancreatic Cancer Therapeutics & Diagnostics Market-Market Dynamics The report details several factors driving and restraining the market, some of which are listed below. Drivers Some factors contributing to the growth of the market are: Large number of unmet needs related to the disease, attracting many multi-national companies to invest in this division Increasing healthcare expenditure Technological developments & drug innovations with regard to the pancreatic cancer Growing concern across the world Restraints Some factors limiting the growth of the market are: Difficulty in diagnosis during the early stages Limited treatment options, especially when the disease has spread to other organs or parts of the body   Inadequate results after treatment Low success rates in clinical trials for cancer drugs High cost associated with the treatment Adverse side-effects High toxicity of drugs   The European pancreatic cancer therapeutics & diagnostic market is segmented based on the type of cancer into endocrine and exocrine cancers. By the type of treatment, the market is segmented into surgery, chemotherapy, radiation therapy and targeted therapy. By the major tests, the market has been segmented into biopsy, endoscopic ultrasound, laparoscopy and CT scan ERCP. On the basis of geography, the market has been segmented into Germany, France, Spain, Italy, the UK and Rest of Europe. Some of the key players in the market are: Amgen, Inc.         Celgene Corporation                                                             Clovis Oncology, Inc.                                                       Eli Lilly and Company                                                             Novartis AG                                 Threshold Pharmaceuticals, Inc.                                                   What the Report Offers Market definition along with identification of key drivers and restraints for the market. Market analysis with region-specific assessments and competition analysis on a global and regional scale. Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale. Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share. Identification and analysis of the macro and micro factors that affect the industry on both global and regional scale. A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information. An ideal source material for industry consultants,  manufacturers and other interested and allied parties to gain a critical insight into the factors driving and restraining the market, in addition to opportunities offered.

Published By: Mordor Intelligence
Published Date: Q2 2016

Get In Touch

Speak to Ananlyst

Enquiry Before Buying

Request for Customization

Request For Discount

Share With Your Friend

Related Reports